Physiological variables and mitochondrial-related genotypes of an athlete who excels in both short and long-distance running

Mitochondrion

Volumn 11, Issue 5, 2011, Pages 774-777

  Eynon, Nir ^a   Birk, Ruth ^a   Meckel, Yoav ^b   Lucia, Alejandro ^c   Nemet, Dan ^d   Eliakim, Alon ^d  

^a ARIEL UNIVERSITY   (Israel)

^b WINGATE INSTITUTE   (Israel)

^c UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^d MEIR MEDICAL CENTER   (Israel)

Author keywords

Endurance athlete; Genetics; Mitochondria

Indexed keywords

ALPHA ACTININ 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR NRF2;

ACTN3 GENE; ADULT; ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; BIOGENESIS; CASE REPORT; CELL FUNCTION; ETHNICITY; GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LUNG GAS EXCHANGE; MALE; MITOCHONDRION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; R577X GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUNNING;

ACTININ; ADULT; ATHLETES; DNA, MITOCHONDRIAL; EXERCISE TEST; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; GENETIC ASSOCIATION STUDIES; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; OXYGEN CONSUMPTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYMORPHISM, GENETIC; RUNNING; SEQUENCE ANALYSIS, DNA; TRACK AND FIELD;

ELAGATIS;

EID: 79961206981     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.05.009     Document Type: Article

References (29)

1. Ahmetov I.I., Mozhayskaya I.A., Flavell D.M., Astratenkova I.V., Komkova A.I., Lyubaeva E.V., Tarakin P.P., Shenkman B.S., Vdovina A.B., Netreba A.I., Popov D.V., Vinogradova O.L., Montgomery H.E., Rogozkin V.A. PPARalpha gene variation and physical performance in Russian athletes. Eur J Appl Physiol 2006, 97:103-108.
2. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., Kelly D.P., Holloszy J.O. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002, 16:1879-1886.
3. Bar-or O., Rowland T.W. Physiologic and perceptual responses to exercise in the healthy child. Human Kinetics, Champaign, Il, USA 2004, 3-60.
4. Druzhevskaya A.M., Ahmetov I.I., Astratenkova I.V., Rogozkin V.A. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol 2008, 103:631-634.
5. Eynon N., Alves A.J., Sagiv M., Yamin C., Sagiv M., Meckel Y. Interaction between SNPs in the NRF2 gene and elite endurance performance. Physiol Genomics 2010, 41:78-81.
6. Eynon N., Meckel Y., Sagiv M., Yamin C., Amir R., Sagiv M., Goldhammer E., Duarte J.A., Oliveira J. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes?. Scand J Med Sci Sports 2009, 20:e145-e150.
7. Eynon N., Meckel Y., Alves A.J., Yamin C., Sagiv M., Goldhammer E., Sagiv M. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?. Exp Physiol 2009, 94:1147-1152.
8. Eynon N., Sagiv M., Meckel Y., Duarte J.A., Alves A.J., Yamin C., Sagiv M., Goldhammer E., Oliveira J. d. NRF2 intron 3 A/G polymorphism is associated with endurance athletes' status. J Appl Physiol 2009, 107:76-79.
9. Eynon N., Duarte J.A., Oliveira J., Sagiv M., Yamin C., Meckel Y., Sagiv M., Goldhammer E. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med 2009, 30:695-698.
10. Eynon N., Ruiz J.R., Meckel Y., Moran M., Lucia A. Mitochondrial biogenesis related endurance genotype score and sports performance in athletes. Mitochondrion 2011, 11:64-69.
11. He Z., Hu Y., Feng L., Li Y., Liu G., Xi Y., Wen L., Lucia A. NRF-1 genotypes and endurance exercise capacity in young Chinese men. Br J Sports Med 2008, 42:361-366.
12. Lucia A., Gomez-Gallego F., Barroso I., Rabadan M., Bandres F., San Juan A.F., Chicharro J.L., Ekelund U., Brage S., Earnest C.P., Wareham N.J., Franks P.W. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 2005, 99:344-348.
13. Lucia A., Rabadan M., Hoyos J., Hernandez-Capilla M., Perez M., San Juan A.F., Earnest C.P., Chicharro J.L. Frequency of the VO2max plateau phenomenon in world-class cyclists. Int J Sports Med 2006, 27:984-992.
14. Mahoney D.J., Parise G., Melov S., Safdar A., Tarnopolsky M.A. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 2005, 19:1498-1500.
15. Mole P.A., Oscai L.B., Holloszy J.O. Adaptation of muscle to exercise. Increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl Coa dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 1971, 50:2323-2330.
16. Niemi A.K., Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005, 13:965-969.
17. Norrbom J., Sundberg C.J., Ameln H., Kraus W.E., Jansson E., Gustafsson T. PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 2004, 96:189-194.
18. Ostrander E.A., Huson H.J., Ostrander G.K. Genetics of athletic performance. Ann Rev Gen Hum Genet 2009, 10:407-429.
19. Rankinen T., Roth S.M., Bray M.S., Loos R., Perusse L., Wolfarth B., Hagberg J.M., Bouchard C. Advances in exercise, fitness, and performance genomics. Med Sci Sports Exerc 2010, 42:835-846.
20. Rubio J.C., Martin M.A., Rabadan M., Gomez-Gallego F., San Juan A.F., Alonso J.M., Chicharro J.L., Perez M., Arenas J., Lucia A. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?. J Appl Physiol 2005, 98:2108-2112.
21. Ruiz J.R., Gomez-Gallego F., Santiago C., Gonzalez-Freire M., Verde Z., Foster C., Lucia A. Is there an optimum endurance polygenic profile?. J Physiol 2009, 587:1527-1534.
22. Russell A.P., Feilchenfeldt J., Schreiber S., Praz M., Crettenand A., Gobelet C., Meier C.A., Bell D.R., Kralli A., Giacobino J.P., Deriaz O. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 2003, 52:2874-2881.
23. Santiago C., Ruiz J.R., Muniesa C.A., Gonzalez-Freire M., Gomez-Gallego F., Lucia A. Does the polygenic profile determine the potential for becoming a world-class athlete? Insights from the sport of rowing. Scand J Med Sci Sports 2010, 20:e188-e194.
24. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Rizza R.A., Coenen-Schimke J.M., Nair K.S. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003, 52:1888-1896.
25. Skogsberg J., Kannisto K., Cassel T.N., Hamsten A., Eriksson P., Ehrenborg E. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscle Thromb Vasc Biol 2003, 23:637-643.
26. Spencer M.R., Gastin P.B. Energy system contribution during 200- to 1500-m running in highly trained athletes. Med Sci Sports Exerc 2001, 33:157-162.
27. Terada S., Goto M., Kato M., Kawanaka K., Shimokawa T., Tabata I. Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 2002, 296:350-354.
28. Van Damme R., Wilson R.S., Vanhooydonck B., Aerts P. Performance constraints in decathletes. Nature 2002, 415:755-756.
29. Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H., Easteal S., North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003, 73:627-631.